Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
Saved in:
| Published in: | The Oncologist |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301676797394945 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | The Oncologist |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61417 |
| institution | FRELIP |
| journal_source_facet | The Oncologist |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis |
| title_auth | Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis |
| title_full | Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis |
| title_fullStr | Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis |
| title_full_unstemmed | Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis |
| title_short | Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis |
| title_sort | prevalence of adverse events following t-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis |
| topic | Oncology General Oncology |
| url | https://academic.oup.com/oncolo/article/doi/10.1093/oncolo/oyag172/8666983?rss=1 |